Chugai A traces the transformative journey of a leading Japanese biopharmaceutical firm from its founding in 1925 to the early 2000s. Starting with founder Jz Ueno's vision to 'create medicines that ...
Sana Biotechnology (SANA) shares have caught the eye lately, with investors tracking shifts in the biotech landscape and the company’s ongoing pipeline developments. There is growing interest as Sana ...
The exemplary, loyal and rare relationship stands as the greatest achievement and most valuable asset that Vietnam and Cuba ...
Zacks Investment Research on MSN
Can NTLA's In Vivo Pipeline Drive Long-Term Growth Amid Rivalry?
Intellia Therapeutics NTLA has made good progress with the advancement of its in vivo candidate, lonvo-z (or, NTLA-2002), ...
Professor, Dr. Henry Nguyen was elected as a Fellow of the National Academy of Innovation, United States, affirming his ...
Jyong Biotech advances plant-derived carotenoid drugs with MCS-2 for BPH and early programs like MCS-8 showing signals as ...
Nanjing Leads Biolabs Co., Ltd. Class H ( ($HK:9887) ) just unveiled an update. Nanjing Leads Biolabs Co., Ltd. has announced the closure of its H ...
A moratorium on artificial intelligence would weaken public oversight and freeze state protections at the very moment we need ...
Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback